Literature DB >> 34193602

HLA-DR Marks Recently Divided Antigen-Specific Effector CD4 T Cells in Active Tuberculosis Patients.

Rashmi Tippalagama1, Akul Singhania1, Paige Dubelko1, Cecilia S Lindestam Arlehamn1, Austin Crinklaw1, Mikhail Pomaznoy1, Gregory Seumois1, Aruna D deSilva1,2, Sunil Premawansa3, Dhammika Vidanagama4, Bandu Gunasena5, N D Suraj Goonawardhana2, Dinuka Ariyaratne2, Thomas J Scriba6, Robert H Gilman7,8, Mayuko Saito9, Randy Taplitz10, Pandurangan Vijayanand1,11, Alessandro Sette1,11, Bjoern Peters12,11, Julie G Burel12.   

Abstract

Upon Ag encounter, T cells can rapidly divide and form an effector population, which plays an important role in fighting acute infections. In humans, little is known about the molecular markers that distinguish such effector cells from other T cell populations. To address this, we investigated the molecular profile of T cells present in individuals with active tuberculosis (ATB), where we expect Ag encounter and expansion of effector cells to occur at higher frequency in contrast to Mycobacterium tuberculosis-sensitized healthy IGRA+ individuals. We found that the frequency of HLA-DR+ cells was increased in circulating CD4 T cells of ATB patients, and was dominantly expressed in M. tuberculosis Ag-specific CD4 T cells. We tested and confirmed that HLA-DR is a marker of recently divided CD4 T cells upon M. tuberculosis Ag exposure using an in vitro model examining the response of resting memory T cells from healthy IGRA+ to Ags. Thus, HLA-DR marks a CD4 T cell population that can be directly detected ex vivo in human peripheral blood, whose frequency is increased during ATB disease and contains recently divided Ag-specific effector T cells. These findings will facilitate the monitoring and study of disease-specific effector T cell responses in the context of ATB and other infections.
Copyright © 2021 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34193602      PMCID: PMC8516689          DOI: 10.4049/jimmunol.2100011

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  70 in total

Review 1.  The who's who of T-cell differentiation: human memory T-cell subsets.

Authors:  Yolanda D Mahnke; Tess M Brodie; Federica Sallusto; Mario Roederer; Enrico Lugli
Journal:  Eur J Immunol       Date:  2013-10-30       Impact factor: 5.532

Review 2.  Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity.

Authors:  Federica Sallusto; Antonio Lanzavecchia
Journal:  Eur J Immunol       Date:  2009-08       Impact factor: 5.532

3.  CD8+ T cells specific for EBV, cytomegalovirus, and influenza virus are activated during primary HIV infection.

Authors:  Jean-Marc Doisne; Alejandra Urrutia; Christine Lacabaratz-Porret; Cécile Goujard; Laurence Meyer; Marie-Laure Chaix; Martine Sinet; Alain Venet
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

4.  Cutting Edge: Characterization of Human Tissue-Resident Memory T Cells at Different Infection Sites in Patients with Tuberculosis.

Authors:  Qianting Yang; Mingxia Zhang; Qi Chen; Weixin Chen; Cailin Wei; Kun Qiao; Taosheng Ye; Guofang Deng; Jin Li; Jialou Zhu; Yi Cai; Xinchun Chen; Li Ma
Journal:  J Immunol       Date:  2020-03-30       Impact factor: 5.422

Review 5.  Cytotoxic CD4 T cells in antiviral immunity.

Authors:  Nikki B Marshall; Susan L Swain
Journal:  J Biomed Biotechnol       Date:  2011-11-22

6.  Clonal analysis of the T-cell response to in vivo expressed Mycobacterium tuberculosis protein Rv2034, using a CD154 expression based T-cell cloning method.

Authors:  Susanna Commandeur; Mariateresa Coppola; Karin Dijkman; Annemieke H Friggen; Krista E van Meijgaarden; Susan J F van den Eeden; Louis Wilson; Jolien J van der Ploeg-van Schip; Kees L M C Franken; Annemieke Geluk; Tom H M Ottenhoff
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

7.  A Quantitative Analysis of Complexity of Human Pathogen-Specific CD4 T Cell Responses in Healthy M. tuberculosis Infected South Africans.

Authors:  Cecilia S Lindestam Arlehamn; Denise M McKinney; Chelsea Carpenter; Sinu Paul; Virginie Rozot; Edward Makgotlho; Yolande Gregg; Michele van Rooyen; Joel D Ernst; Mark Hatherill; Willem A Hanekom; Bjoern Peters; Thomas J Scriba; Alessandro Sette
Journal:  PLoS Pathog       Date:  2016-07-13       Impact factor: 6.823

8.  Analysis of Allergen-Specific T Cell and IgE Reactivity to Different Preparations of Cow's Milk-Containing Food Extracts.

Authors:  Meng Chen; Aaron Sutherland; Giovanni Birrueta; Susan Laubach; Stephanie Leonard; Bjoern Peters; Véronique Schulten
Journal:  Cells       Date:  2019-07-02       Impact factor: 6.600

9.  TopHat: discovering splice junctions with RNA-Seq.

Authors:  Cole Trapnell; Lior Pachter; Steven L Salzberg
Journal:  Bioinformatics       Date:  2009-03-16       Impact factor: 6.937

10.  IPD-IMGT/HLA Database.

Authors:  James Robinson; Dominic J Barker; Xenia Georgiou; Michael A Cooper; Paul Flicek; Steven G E Marsh
Journal:  Nucleic Acids Res       Date:  2020-01-08       Impact factor: 16.971

View more
  7 in total

1.  Single cell transcriptomics and TCR reconstruction reveal CD4 T cell response to MHC-II-restricted APOB epitope in human cardiovascular disease.

Authors:  Ryosuke Saigusa; Payel Roy; Antoine Freuchet; Rishab Gulati; Yanal Ghosheh; Sujit Silas Armstrong Suthahar; Christopher P Durant; David B Hanna; William B Kiosses; Marco Orecchioni; Lai Wen; Runpei Wu; Mark H Kuniholm; Alan L Landay; Kathryn Anastos; Phyllis C Tien; Stephen J Gange; Seble Kassaye; Jenifer Vallejo; Catherine C Hedrick; William W Kwok; Alessandro Sette; Howard N Hodis; Robert C Kaplan; Klaus Ley
Journal:  Nat Cardiovasc Res       Date:  2022-05-12

2.  Lung Spatial Profiling Reveals a T Cell Signature in COPD Patients with Fatal SARS-CoV-2 Infection.

Authors:  Chen Xi Yang; Michael Tomchaney; Manuel F Landecho; Borja R Zamacona; Marta Marin Oto; Javier Zulueta; Joshua Malo; Steve Knoper; Marco Contoli; Alberto Papi; Dragoş M Vasilescu; Maor Sauler; Christof Straub; Cheryl Tan; Fernando D Martinez; Deepta Bhattacharya; Ivan O Rosas; Farrah Kheradmand; Tillie-Louise Hackett; Francesca Polverino
Journal:  Cells       Date:  2022-06-07       Impact factor: 7.666

3.  Identification of a Disease-Associated Network of Intestinal Immune Cells in Treatment-Naive Inflammatory Bowel Disease.

Authors:  Vincent van Unen; Laura F Ouboter; Na Li; Mette Schreurs; Tamim Abdelaal; Yvonne Kooy-Winkelaar; Guillaume Beyrend; Thomas Höllt; P W Jeroen Maljaars; M Luisa Mearin; Ahmed Mahfouz; Anne M C Witte; Cornelis H M Clemens; Sunje Abraham; Johanna C Escher; Boudewijn P F Lelieveldt; M Fernanda Pascutti; Andrea E van der Meulen-de Jong; Frits Koning
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

4.  Seroma after Simple Mastectomy in Breast Cancer-The Role of CD4+ T Helper Cells and the Evidence as a Possible Specific Immune Process.

Authors:  Nicole Pochert; Mariella Schneider; Nadine Ansorge; Annamarie Strieder; Jacqueline Sagasser; Matthias Reiger; Claudia Traidl-Hoffmann; Avidan Neumann; Udo Jeschke; Christian Dannecker; Thorsten Kühn; Nina Ditsch
Journal:  Int J Mol Sci       Date:  2022-04-27       Impact factor: 6.208

Review 5.  Tuberculosis Phenotypic and Genotypic Drug Susceptibility Testing and Immunodiagnostics: A Review.

Authors:  Kizil A Yusoof; Juan Ignacio García; Alyssa Schami; Andreu Garcia-Vilanova; Holden V Kelley; Shu-Hua Wang; Adrian Rendon; Blanca I Restrepo; Marcel Yotebieng; Jordi B Torrelles
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

6.  Biologic Agents in Crohn's Patients Reduce CD4+ T Cells Activation and Are Inversely Related to Treg Cells.

Authors:  Eliane Aparecida Rosseto-Welter; Leticia D'argenio-Garcia; Filipa Blasco Tavares Pereira Lopes; Ana Eduarda Zulim Carvalho; Fernando Flaquer; Vanessa Severo-Lemos; Claudia Concer Viero Nora; Flavio Steinwurz; Lucas Pires Garcia Oliveria; Thiago Aloia; Luiz Vicente Rizzo; Cristóvão Luis Pitangueira Mangueira; Karina Inacio Carvalho
Journal:  Can J Gastroenterol Hepatol       Date:  2022-07-31

7.  Study of CD27, CD38, HLA-DR and Ki-67 immune profiles for the characterization of active tuberculosis, latent infection and end of treatment.

Authors:  Sergio Díaz-Fernández; Raquel Villar-Hernández; Zoran Stojanovic; Marco Fernández; Maria Luiza De Souza Galvão; Guillermo Tolosa; Adrián Sánchez-Montalva; Jorge Abad; María Ángeles Jiménez-Fuentes; Guillem Safont; Iris Romero; Josefina Sabrià; Cristina Prat; Jose Domínguez; Irene Latorre
Journal:  Front Microbiol       Date:  2022-07-22       Impact factor: 6.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.